
CAS 1263131-92-5
:[1,1'-Biphenyl]-4-carboxaMide, N-[5-[[iMino[(3,4,5-triMethoxybenzoyl)aMino]Methyl]aMino]-2-Methylphenyl]-
Description:
The chemical substance known as "[1,1'-Biphenyl]-4-carboxamide, N-[5-[[imino[(3,4,5-trimethoxybenzoyl)amino]methyl]amino]-2-methylphenyl]-" with CAS number 1263131-92-5 is a complex organic compound characterized by its biphenyl structure and multiple functional groups. It features a carboxamide moiety, which is known for its ability to form hydrogen bonds, enhancing solubility and reactivity. The presence of trimethoxybenzoyl and amino groups suggests potential biological activity, possibly as a pharmaceutical agent or in biochemical applications. The compound's structure indicates it may exhibit specific interactions with biological targets, making it of interest in medicinal chemistry. Additionally, the presence of multiple aromatic rings contributes to its stability and potential for π-π stacking interactions. Overall, this compound's unique structural features and functional groups may confer specific properties that are valuable in various chemical and biological contexts. Further studies would be necessary to elucidate its full range of characteristics and potential applications.
Formula:C31H30N4O5
Synonyms:- MRT-83
- Inhibitor,MRT-83,MRT83,Smo,MRT 83,inhibit,Smoothened
- [1,1'-Biphenyl]-4-carboxaMide, N-[5-[[iMino[(3,4,5-triMethoxybenzoyl)aMino]Methyl]aMino]-2-Methylphenyl]-
- N-[amino-[4-methyl-3-[(4-phenylbenzoyl)amino]anilino]methylidene]-3,4,5-trimethoxybenzamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
MRT-83
CAS:<p>MRT-83 is a potent Smo antagonist.</p>Formula:C31H30N4O5Purity:99.81%Color and Shape:SolidMolecular weight:538.59MRT-83
CAS:<p>MRT-83 is a drug candidate that has been shown to be active against leukemia cells, brain cancer cells, and breast cancer cells. MRT-83 binds to the cilium of human leukemia cells and inhibits the formation of hydrogen bonds. This leads to a disruption in the function of the cilium and subsequent cellular death. MRT-83 also binds to vitamin D3 in the body, which may lead to its clinical use in treating bone loss due to cancer treatment. Clinical development for MRT-83 is underway at this time.</p>Formula:C31H30N4O5Purity:Min. 95%Molecular weight:538.6 g/mol




